Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference34 articles.
1. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008;57:3169–76.
2. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005;28:1245–9.
3. Khunti K, Alsifri S, Aronson R, et al. Impact of hypoglycaemia on patient reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin treated type 2 diabetes. Diabetes Res Clin Pract. 2017;130:121–9.
4. Novo Nordisk A/S. Tresiba (Insulin Degludec) summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/tresiba-epar-product-information_en.pdf. Accessed Dec 2019.
5. Heise T, Hermanski L, Nosek L, Feldman A, Rasmussen S, Haahr H. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes. Diabetes Obes Metab. 2012;14:859–64.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献